MacroGenics
MGNX
N/A
Share price
0.76%
Change (1 day)
N/A
Change (1 year)
Categories
Market capitalization of MacroGenics (MGNX)
Market cap: N/A
As of June 2025 MacroGenics has a market cap of N/A. This makes MacroGenics the world's 9298th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of MacroGenics from 2020 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | N/A | -100% |
| 2024 | A$0.32 B | -93.01% |
| 2023 | A$4.66 B | 44.6% |
| 2022 | A$3.22 B | 137.46% |
| 2021 | A$1.35 B | -18.83% |
| 2020 | A$1.67 B |
End of Day market cap according to different sources
On Jun 23rd, 2025 the market cap of MacroGenics was reported to be:
N/A
N/A
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Xencor XNCR | N/A | N/A | 🇺🇸 USA |
 Pfizer PFE | N/A | N/A | 🇺🇸 USA |
 Merck MRK | N/A | N/A | 🇺🇸 USA |
 Gilead Sciences GILD | N/A | N/A | 🇺🇸 USA |
 Amgen AMGN | N/A | N/A | 🇺🇸 USA |
 Eli Lilly LLY | N/A | N/A | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | N/A | N/A | 🇺🇸 USA |